Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01756612
Other study ID # ML28145
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 21, 2012
Est. completion date March 25, 2015

Study information

Verified date July 2019
Source Hoffmann-La Roche
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This prospective, multicenter, observational study will evaluate the impact of comorbidity factors on the hemoglobin level in participants with chronic kidney disease who are not on dialysis and initiated on treatment with methoxy polyethylene glycol-epoetin beta (Mircera). Data will be collected for 9 months after initiation of methoxy polyethylene glycol-epoetin beta treatment.


Recruitment information / eligibility

Status Completed
Enrollment 551
Est. completion date March 25, 2015
Est. primary completion date March 25, 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Participants with chronic kidney disease not on dialysis

- Treatment-naïve for erythropoiesis-stimulating agents (ESAs), not having received ESAs in the 6 months prior to inclusion in this study

- Hemoglobin level less then (<)10 grams per deciliter (g/dL) at inclusion

- Participants for whom the treating physician has decided to initiate treatment with methoxy polyethylene glycol-epoetin beta for medical reasons prior to study start

Exclusion Criteria:

- Functional renal transplant

- Current participation in a clinical trial in anemia due to chronic kidney disease

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Methoxy Polyethylene Glycol-Epoetin Beta
Methoxy polyethylene glycol-epoetin beta will be administered at the discretion of treating physician. Study protocol does not specify any treatment regimen.

Locations

Country Name City State
France CHP Aix Aix En Provence
France Ch Notre Dame Misericorde; Hemodialyse Ajaccio
France Chi D Alencon;Nephrologie Hemodialyse Alencon
France Centre Aider Ales
France Hotel Dieu; Nephrologie Hemodialyse Angers
France Centre Hospitalier; Hemodialyse Annonay
France Centre Hemodialyse La Riviera Antibes
France Ch D Arras; Nephrologie Arras
France Chp Aubagne Aubagne
France Ch Henri Duffaut; Nephrologie Hemodialyse Avignon
France Chic Cote Basque Bayonne; Nephrologie Hemodialyse Bayonne
France Ch De Beauvais; Neph Endocrino Dialyse Diabeto Beauvais
France Centre D Hemodialyse Regina Belley
France CHU Saint Jacques; Centre De Dialyse Besancon
France Ch Germon Et Gauthier; Medecine Interne Nephrologie Beuvry
France CNB - Centre Nephrologie Du Biterrois Beziers
France Cabinet Medical Bordeaux
France Centre Hemodialyse St Augustin; Nephrologie Bordeaux
France Hopital Pellegrin; Departement Nephrologie Bordeaux
France Ch De Fleyriat; Nephrologie Hemodialyse Bourg En Bresse
France Aural; Service Hemodialyse Bourgoin Jallieu
France Hopital La Cavale Blanche; Nephrologie Brest
France Ch de Brive la Gaillarde; Nephrologie Hemodialyse Brive La Gaillarde
France Centre D Hemodialyse Saint Roch Cabestany
France Hopital Clemenceau; Nephrologie Hemodialyse Caen
France Ch Antoine Gayraud; Nephrologie Hemodialyse Carcassonne
France Centre Hemodialyse Du Lez; Nephrologie Castelnau le Lez
France CH William Morey; Nephrologie Chalon Sur Saone
France Aura Auvergne; Aura Auvergne Chamalieres
France Ch De Chambery; Nephrologie Chambery
France Avitum France; Centre De Nephrologie Chateauroux
France Centre Hospitalier; Hemodialyse Cholet
France Centre De Sante Medical; Centre De Sante Republique Clermont Ferrand
France Hopital Gabriel Montpied Clermont-ferrand
France Ch Laennec; Nephrologie Hemodialyse Creil
France Fondation Transplantation; Ctirc De Drevon Dijon
France Nephrocare Ile De France; Etampes Etampes
France Chi Eure Seine D Evreux; Nephrologie Evreux
France Cabinet Medical Fontaine Les Dijon
France Hopital De Freyming; Nephrologie Freyming Merlebach
France Centre Hospitalier General; Service de Nephrologie-Hemodialyse GAP
France Association Aurad Aquitaine; Aurad Gradignan Gradignan
France Centre de Dialyse Atirra; Service Nephrologie - Hemodialyse Greize
France Ch Dptal Les Oudairies; Nephrologie La Roche Sur Yon
France Agduc Muller La Tronche
France Hopital Albert Michallon; Clinique De Nephrologie La Tronche
France Ch De Laon; Nephrologie Hemodialyse Laon
France Hopital Prive De L Estuaire; Nephrologie Hemodialyse Le Havre
France Ch Emile Roux; Nephrologie Le Puy En Velay
France Hopital Claude Huriez; Nephrologie Lille
France Polyclinique De La Louviere; Nephrologie Lille
France Ctre Hosp St Joseph Et St Luc; Nephrologie Hemodialyse Lyon
France Hopital Edouard-Herriot; Nephrologie - Hemodialyse Lyon
France Clinique Bouchard ; Nephrologie Marseille
France Hopital De La Conception; Hemodialyse Marseille
France Hopital De La Conception; Nephrologie Marseille
France Ch De Meaux; Medecine C Meaux
France Hopital Layne; Nephrologie Hemodialyse Mont De Marsan
France Hopital Hotel Dieu; Medecine Geriatrique Nephrologie Mont St Martin
France Centre D Hemodialyse Sodetir Montereau
France Centre Aider; Centre Aider Montpellier Montpellier
France Centre De Dialyse La Fonderie Mullhouse
France Polyclinique De Gentilly; Hemodialyse Nancy
France Echo Nantes Confluent; Uad Montfort Nantes
France Hopital Hotel Dieu Et Hme; Hemodialyse Chronique Nantes
France Hopital Hotel Dieu Et HME; Nephrologie Immunologie Clinique Nantes
France Hopital Pasteur; Pavillon A Nephrologie Nice
France Centre Gardialyse Nimes
France Ctre Dialyse De La Reine Blanche Orleans
France Hopital de La Source; Service de Nephrologie & Hemodialyse Orleans
France Ch Pitie Salpetriere; Nephrologie Hemodialyse Paris
France Hopital Europeen Georges Pompidou; Service de Nephrologie Paris
France Hopital Saint Louis; Service de Nephrologie - Transplantation Paris
France Hopital Tenon; Nephrologie Dialyse Paris
France Hopital Saint Jean; Nephrologie Perpignan
France Centre Hemodialyse Saint Martin Pessac
France Ch Lyon Sud; Nephrologie Sect Jules Courmont Pierre Benite
France Chi Poissy Saint Germain En Laye; Hemodialyse Poissy
France Chu La Miletrie;Nephrologie Transplantation Poitiers
France Association Pour L'Aide Des Uremiques de Bretagne Quimper
France Hopital Pontchaillou; Nephrologie Rennes
France Clinique De L Europe; Hemodialyse Rouen
France Centre D'Hemodialyse Arnaud Tzanck; Service Nephrologie - Hemodialyse Saint Laurent Du Var
France Memorial France Etats Unis; Nephrologie Saint Lo
France Hopital Broussais; Medecine 4 Saint-malo
France Nephrocare Tassin Charcot; Nephrologie Sainte Foy les Lyon
France Hopital Sud ; Nephrologie Hemodialyse Salouel
France Centre Hospitalier De Sens; Nephrologie-Dialyse Sens
France Ch Gaston Ramon; Nephrologie Sens
France Ch De Soissons; Medecine 5 Soissons
France Chi Du Val D Ariege; Gastro Enterologie Nephrologie St Jean De Verges
France Centre D Hemodialyse St Laurent Du Var
France Institut Arnault Tzanck; Med 2 St Laurent Du Var
France Artic; Bureau St Priest En Jarez
France Hopital Nord; Hopital De Jour St Priest En Jarez
France HOPITAL NORD; NEPH Transplantation Reanimation St Priest En Jarez
France Hopital Civil; Nephrologie Clinique Medicale B Strasbourg
France Hopital Foch; Nephrologie Hemodialyse Suresnes
France Nephrocare Ile de France; Suresnes Suresnes
France Hopital de La Gespe; Dept of Nephrology Tarbes
France Hopitaux Du Leman Site Thonon;Nephrologie Thonon-les-bains
France Hopital Sainte Musse; Nephrologie Toulon
France Hopital Rangueil; Nephrologie Hemodialyse Toulouse
France Clinique de Tournan; Service de Nephrologie Tournan-en-brie
France Hopital Bretonneau; Nephrologie Transplantations Tours
France Ch Bretagne Atlantique De Vannes; Nephrologie Vannes
France Hopital Saint Nicolas; Medecine A Verdun
France Cabinet Medical Villeurbanne

Sponsors (1)

Lead Sponsor Collaborator
Hoffmann-La Roche

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of Participants With an Increase From Baseline in Hemoglobin Level of Greater Than or Equal to (>/=) 1 g/dL or a Hemoglobin Level Between 10 and 12 g/dL After 9 Months of Treatment Without any Transfusional Recourse Baseline, Month 9
Secondary Hemoglobin Levels According to Liu Index and Resistance Factors Baseline, Months 1, 2, 3, 4, 5, 6, 7, 8, 9
Secondary Average Dose of Mircera in Total Population Baseline up to 9 months
Secondary Percentage of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) in Total Population Baseline up to 9 months
Secondary Average Dose of Mircera in Subgroups as Defined by the Comorbidities List Used for the Charlson Comorbidities Index Calculation Baseline up to 9 months
Secondary Percentage of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) in in Subgroups as Defined by the Comorbidities List Used for the Charlson Comorbidities Index Calculation Baseline up to 9 months
Secondary Duration of Treatment With Mircera Baseline up to 9 months
Secondary Number of Participants Who Received Concomitant Treatment (Known as Potentially Resistant Factors) for Renal Anemia Baseline up to 9 month
See also
  Status Clinical Trial Phase
Completed NCT02625844 - Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents in Hemodialysis Centers in Croatia N/A
Completed NCT04885647 - A Study of YPEG-rhEPO in Patients Suffered From Anemia Due to Chronic Kidney Disease Phase 2
Completed NCT02596945 - Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis N/A
Completed NCT02540213 - Observational Study of MIRCERA in Users of Self-Application and Multidose Systems N/A